Skip to main content
S

SCL Science Inc. — Investor Relations & Filings

Ticker · 246960 ISIN · KR7246960009 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2025-12-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 246960

About SCL Science Inc.

https://sclscience.com/en

SCL Science Inc., formerly InnoTherapy Inc., is a healthcare company focused on digital innovation and advanced medical technologies. The company develops and commercializes medical hemostatic agents based on its proprietary biomimetic technology, including the Bio-inspired Medical Materials (BiMM) product line. Leveraging 40 years of expertise in medical science, SCL Science is also dedicated to building a digital healthcare ecosystem using artificial intelligence and high-quality medical data. Its services extend to clinical trial analysis, bio-logistics, and an expanding drug discovery platform focused on AI-driven cancer vaccine development. The company serves hospitals, research laboratories, and other medical institutions.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details changes in share ownership, including the reporter's identity, the number of shares held, the purpose of holding (influencing management), and specific transaction details (bonus issue and market sales). This fits the definition of a Major Shareholding Notification.
2025-12-29 Korean
주권매매거래정지 (영업양수도)
Regulatory Filings Classification · 1% confidence The document is a short, official notice regarding the suspension of stock trading ('주권매매거래정지') for SCL Science due to a business transfer ('영업양수도'). It cites specific KOSDAQ market regulations. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A or financial reports, it falls under the general regulatory filing category.
2025-12-23 Korean
주요사항보고서(영업양수결정)
M&A Activity Classification · 1% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korea Exchange regarding a 'Business Acquisition Decision' (영업양수 결정). It details the acquisition of a business unit from a related party, including financial valuation, payment schedules, and board approval details. This type of regulatory filing for significant corporate transactions (M&A activity) is classified under the 'M&A Activity' category.
2025-12-23 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the procedural steps for the meeting. Given the nature of the announcement as a regulatory disclosure of meeting-related dates, it fits best under the RNS category as a general regulatory filing.
2025-12-18 Korean
[첨부추가]기업설명회(IR)개최
Regulatory Filings
2025-10-01 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Regulatory Filings
2025-09-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.